Blueshift Asset Management LLC Has $268,000 Position in HealthEquity, Inc. $HQY

Blueshift Asset Management LLC lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 79.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,558 shares of the company’s stock after selling 10,108 shares during the period. Blueshift Asset Management LLC’s holdings in HealthEquity were worth $268,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC raised its position in shares of HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in shares of HealthEquity during the 2nd quarter worth about $33,000. WPG Advisers LLC acquired a new position in HealthEquity in the 1st quarter valued at about $28,000. Cullen Frost Bankers Inc. raised its holdings in HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after acquiring an additional 224 shares during the period. Finally, Sellwood Investment Partners LLC acquired a new stake in HealthEquity during the second quarter worth approximately $58,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $95.67 on Friday. The business has a fifty day moving average price of $96.41 and a two-hundred day moving average price of $96.87. The stock has a market capitalization of $8.24 billion, a PE ratio of 43.89, a P/E/G ratio of 1.42 and a beta of 0.18. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.95% and a net margin of 14.86%.HealthEquity’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This represents a 3.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 6,000 shares of HealthEquity stock in a transaction that occurred on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This trade represents a 7.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 10,781 shares of company stock valued at $1,016,707 over the last 90 days. Corporate insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on HQY. JPMorgan Chase & Co. upped their target price on HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research report on Thursday. Jefferies Financial Group boosted their price target on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, September 3rd. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research report on Thursday. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Finally, Royal Bank Of Canada upped their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $120.07.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.